Answers are grounded in this paper and cite their sources.
Background Natamycin is a polyene macrolide antifungal antibiotic synthesized by several Streptomyces species, among which Streptomyces natalensis is one of the most widely exploited producers. Although the cluster-located pimH gene is predicted to encode a major facilitator superfamily (MFS) transporter, its authentic role in natamycin export and its operating mechanism remain uncharacterized in this strain. Results In this study, we demonstrate that PimH serves as the efflux transporter responsible for natamycin export. Constitutive overexpression of pimH prolonged natamycin production and increased natamycin titers by up to 65.9% at day 7 relative to the wild type. High-level pimH expression increased the proportion of extracellular natamycin by 20% during late fermentation and markedly enhanced tolerance to exogenous natamycin. Electron microscopy revealed that pimH overexpression accelerates morphological differentiation, coinciding with higher antibiotic production. Transcriptomic analyses further showed global up-regulation of the pim biosynthetic gene cluster in the engineered strain, underscoring the pleiotropic impact of elevated pimH expression. Furthermore, combinatorial overexpression of pimH together with the transcriptional activator genes pimM and pimR increased natamycin titers by up to 115.4%. Conclusions These findings establish PimH-mediated efflux as a critical determinant of natamycin productivity and offer a rational target for the metabolic engineering of high-yield industrial strains.
No takes yet. Share an insight, caveat, or question.
Qi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: